Alert Indications, Safety, and Warnings

i-PORT ADVANCETM INJECTION PORT Let’s reduce needle anxiety, together.1

The i-Port AdvanceTM injection port offers patients on multiple daily injections (MDI) a way to take their insulin without having to puncture their skin for each shot.

REQUEST INFO
i-Port Advance injection port and insertion device.
Alert Indications, Safety, and Warnings

Overview

INJECTIONS ARE A DAILY BURDEN FOR YOUR PATIENTS

Icon of 3 syringes, 2 with a line through them.  83% want to inject less2     Calendar icon.  79% skip injections2     Icon of a blue X in a circle. 74% discontinue insulin therapy3

    

LIFE WITH INJECTIONS
CAN BE EASIER

The i-Port AdvanceTM injection port includes a built-in inserter, which enables a quick application. Once inserted, only a soft flexible tube, called a cannula, remains under the skin allowing for direct medication delivery from an insulin syringe or an insulin pen into the subcutaneous tissue.

  • Approved for all ages and prescribed subcutaneous medication
  • Use with syringe or pen (needles 5-8mm in length, 28-32 gauge)
  • Change every three days
  • Easy application, minimal training required
  • Discreet; fits into daily activities

Illustration showing an injetion using i-Port Advance.

 

  

FDA CLEARED

For use in patients who receive multiple daily subcutaneous injections of physician-prescribed medications3

PRACTICAL

Can be used for up to 72 hours to accommodate up to 75 injections4

VERSITILE

Can be worn:

  • at home
  • while exercising
  • while sleeping
  • when bathing

  

  

A SOLUTION THAT HELPS IMPROVE THE QUALITY OF LIFE

The i-Port AdvanceTM injection port reduces patient anxiety and discomfort associated with MDI.4

100% helped decrease anxiety1

99% more beneficial than injections1

100% comfortable to wear1

PRESCRIBE i-PORT ADVANCETM INJECTION PORT FOR YOUR PATIENTS WHO:

  • Experience pain, fear or anxiety due to injections
  • Are new to injections or hesitant to start
  • Skip injection(s)

Especially:

  • Children newly diagnosed with type 1 diabetes
  • Patients with type 2 diabetes who are new to insulin or multiple daily injections

  

  

REQUEST MORE INFORMATION

Complete the form below and a representative will follow up with additional information.

This form is for Healthcare Professionals. If you are a patient looking for more information click here

* Indicates a required field.

Your information will be used and protected in accordance with our privacy statement.

i-PORT ADVANCETM INJECTION PORT
INSERTION VIDEO

In this video, you will learn how to apply, use, and remove the i-Port AdvanceTM injection port.

IMPORTANT SAFETY INFORMATION: i-PORT ADVANCE™ INJECTION PORT

i-Port AdvanceTM injection port is prescription-indicated for patients who administer, or to whom is administered, multiple daily subcutaneous injections of physician prescribed medications, including insulin. The device may remain in place for up to 72 hours to accommodate multiple drug injections without the discomfort of additional needle sticks. Site infection and/or irritation is a risk. Patients experiencing such symptoms should immediately consult their healthcare provider and/ or discontinue use. For complete details, please consult i-PortTM Advance product user guide.

1

Riley D, Raup G. Impact of a subcutaneous injection device on improving patient care. Nurse Manage. 2010;41(6):49–50 Prospective study conducted in an inpatient setting, in which 100 patients requiring multiple subcutaneous injections of insulin were offered i-Port; 39 of 100 patients reported needle anxiety prior to using i-Port.

2

American Association of Diabetes Educators. Injection impact report. http://www.injectionimpact.com/index.html. Published 2008. Accessed May 1, 2015;  

3

Oliveria SA, Menditto LA, Yood MU, Koo YH, Wells KE, McCarthy BD. Barriers to the initiation of, and persistence with, insulin therapy. Curr Med Res Opin. 2007;23(12):3105–3112

4

FDA. i-Port Advance injection port. FDA approval. 2012.